nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0333	0.0333	CbGpPWpGaD
Galantamine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0291	0.0291	CbGpPWpGaD
Galantamine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0276	0.0276	CbGpPWpGaD
Galantamine—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0264	0.0264	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0251	0.0251	CbGpPWpGaD
Galantamine—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0248	0.0248	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—TNFRSF11B—osteoarthritis	0.0239	0.0239	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0219	0.0219	CbGpPWpGaD
Galantamine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0209	0.0209	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0208	0.0208	CbGpPWpGaD
Galantamine—CHRNG—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0198	0.0198	CbGpPWpGaD
Galantamine—CHRNA9—Neuronal System—CAMK2B—osteoarthritis	0.0192	0.0192	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0186	0.0186	CbGpPWpGaD
Galantamine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0184	0.0184	CbGpPWpGaD
Galantamine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoarthritis	0.018	0.018	CbGpPWpGaD
Galantamine—CHRNB3—Neuronal System—CAMK2B—osteoarthritis	0.0168	0.0168	CbGpPWpGaD
Galantamine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoarthritis	0.0161	0.0161	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—CAMK2B—osteoarthritis	0.0159	0.0159	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0157	0.0157	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—CAMK2B—osteoarthritis	0.0152	0.0152	CbGpPWpGaD
Galantamine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoarthritis	0.0149	0.0149	CbGpPWpGaD
Galantamine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0147	0.0147	CbGpPWpGaD
Galantamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0145	0.0145	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—CAMK2B—osteoarthritis	0.0143	0.0143	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0139	0.0139	CbGpPWpGaD
Galantamine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoarthritis	0.0133	0.0133	CbGpPWpGaD
Galantamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0133	0.0133	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.0131	0.0131	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.0129	0.0129	CbGpPWpGaD
Galantamine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0126	0.0126	CbGpPWpGaD
Galantamine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0125	0.0125	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—CAMK2B—osteoarthritis	0.0121	0.0121	CbGpPWpGaD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0118	0.0118	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.011	0.011	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0109	0.0109	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—CAMK2B—osteoarthritis	0.0106	0.0106	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.0103	0.0103	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0103	0.0103	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00998	0.00998	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00947	0.00947	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00942	0.00942	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00937	0.00937	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00894	0.00894	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0089	0.0089	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—CAMK2B—osteoarthritis	0.00844	0.00844	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—CAMK2B—osteoarthritis	0.00836	0.00836	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00772	0.00772	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—CAMK2B—osteoarthritis	0.00764	0.00764	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00742	0.00742	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00729	0.00729	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—CAMK2B—osteoarthritis	0.00725	0.00725	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—CAMK2B—osteoarthritis	0.00718	0.00718	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—IL1B—osteoarthritis	0.00693	0.00693	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—CAMK2B—osteoarthritis	0.00682	0.00682	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00644	0.00644	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—ESR1—osteoarthritis	0.00636	0.00636	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—LEP—osteoarthritis	0.00629	0.00629	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—CAMK2B—osteoarthritis	0.00591	0.00591	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00551	0.00551	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—MMP2—osteoarthritis	0.00533	0.00533	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00525	0.00525	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00512	0.00512	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—TNF—osteoarthritis	0.00503	0.00503	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—LEP—osteoarthritis	0.00498	0.00498	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00491	0.00491	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00491	0.00491	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—LEP—osteoarthritis	0.00444	0.00444	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—CXCL8—osteoarthritis	0.00443	0.00443	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CAMK2B—osteoarthritis	0.00422	0.00422	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—IGF1—osteoarthritis	0.00411	0.00411	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00403	0.00403	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00387	0.00387	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.0038	0.0038	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CAMK2B—osteoarthritis	0.00376	0.00376	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—IGF1—osteoarthritis	0.00367	0.00367	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ADAMTS13—osteoarthritis	0.00359	0.00359	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.00356	0.00356	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.0035	0.0035	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00339	0.00339	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ADAMTS5—osteoarthritis	0.00337	0.00337	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ADAMTS3—osteoarthritis	0.00337	0.00337	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00336	0.00336	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ADAMTS13—osteoarthritis	0.0032	0.0032	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ADAMTS5—osteoarthritis	0.00301	0.00301	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ADAMTS3—osteoarthritis	0.00301	0.00301	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.00288	0.00288	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ADAMTS4—osteoarthritis	0.00287	0.00287	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTO1—osteoarthritis	0.00286	0.00286	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00285	0.00285	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTO1—osteoarthritis	0.00282	0.00282	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.00281	0.00281	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00274	0.00274	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ADAMTS4—osteoarthritis	0.00256	0.00256	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IL6—osteoarthritis	0.00249	0.00249	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00249	0.00249	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.00244	0.00244	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—IL6—osteoarthritis	0.00235	0.00235	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.00226	0.00226	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00215	0.00215	CbGpPWpGaD
Galantamine—ACHE—Metabolism—FMOD—osteoarthritis	0.00208	0.00208	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.00199	0.00199	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.00197	0.00197	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.00187	0.00187	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FMOD—osteoarthritis	0.00185	0.00185	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.00184	0.00184	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00178	0.00178	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGES—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—HSPA5—osteoarthritis	0.00164	0.00164	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.0016	0.0016	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGES—osteoarthritis	0.00151	0.00151	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—HSPA5—osteoarthritis	0.00146	0.00146	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00129	0.00129	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.0012	0.0012	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTO1—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BGN—osteoarthritis	0.00115	0.00115	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTO1—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Galantamine—BCHE—Metabolism—BGN—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP1—osteoarthritis	0.000971	0.000971	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LEP—osteoarthritis	0.00094	0.00094	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP1—osteoarthritis	0.000866	0.000866	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FMOD—osteoarthritis	0.000851	0.000851	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LEP—osteoarthritis	0.000838	0.000838	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF1—osteoarthritis	0.000776	0.000776	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—osteoarthritis	0.000751	0.000751	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000745	0.000745	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000694	0.000694	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—osteoarthritis	0.000693	0.000693	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—osteoarthritis	0.00067	0.00067	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000665	0.000665	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—osteoarthritis	0.000624	0.000624	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—osteoarthritis	0.000557	0.000557	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000557	0.000557	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTO1—osteoarthritis	0.000489	0.000489	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BGN—osteoarthritis	0.000473	0.000473	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000454	0.000454	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—osteoarthritis	0.000332	0.000332	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.00032	0.00032	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BGN—osteoarthritis	0.00031	0.00031	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—osteoarthritis	0.000296	0.000296	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—osteoarthritis	0.000136	0.000136	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—osteoarthritis	8.9e-05	8.9e-05	CbGpPWpGaD
